Kubota T
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Nov;38(11):2057-64.
Herpes Simplex Virus 2 (HSV-2) has become the object of public attention as an etiological cause of cervical cancer. Uneven distribution of HSV antigen in tissue was examined dy dyeing tissue materials of cervical intraepithelial neoplasia by the method called peroxidase-antiperoxidase using HSV-2 antibody. The positive rate in the control group was 10.3%, while it was 10.7% in the mild dysplasia group, 17.5% in the moderate dysplasia group, 25.5% in the severe dysplasia group, 31.3% in the carcinoma in situ (CIS) group and 41.4% in the cervical cancer group. The positive rate in the cervical cancer group showed a significant difference from the control, mild displasia, moderate dysplasia and severe dysplasia groups (p less than 0.01). The rate in the CIS group demonstrated a significant difference from the control and mild dysplasia groups (p less than 0.05, p less than 0.01). The rate in the severe dysplasia group showed a significant difference from the control and mild dysplasia groups (p less than 0.05, p less than 0.01). The positive rate in the cervical cancer group in patients 40 approximately 49 years of age was significantly higher than that in the control and mild dysplasia groups (p less than 0.01). It also showed a significant difference from the moderate dysplasia and severe dysplasia groups (p less than 0.05). The rate in the cervical cancer group in patients aged 50 approximately 59 years showed a significant difference from the control, moderate dysplasia and mild dysplasia groups (p less than 0.05, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
单纯疱疹病毒2型(HSV - 2)作为宫颈癌的病因已成为公众关注的对象。采用过氧化物酶 - 抗过氧化物酶法,使用HSV - 2抗体对宫颈上皮内瘤变组织材料进行染色,检测组织中HSV抗原的分布不均情况。对照组的阳性率为10.3%,轻度发育异常组为10.7%,中度发育异常组为17.5%,重度发育异常组为25.5%,原位癌(CIS)组为31.3%,宫颈癌组为41.4%。宫颈癌组的阳性率与对照组、轻度发育异常组、中度发育异常组和重度发育异常组相比有显著差异(p小于0.01)。CIS组的阳性率与对照组和轻度发育异常组有显著差异(p小于0.05,p小于0.01)。重度发育异常组的阳性率与对照组和轻度发育异常组有显著差异(p小于0.05,p小于0.01)。40至49岁患者的宫颈癌组阳性率显著高于对照组和轻度发育异常组(p小于0.01)。与中度发育异常组和重度发育异常组相比也有显著差异(p小于0.05)。50至59岁患者的宫颈癌组阳性率与对照组、中度发育异常组和轻度发育异常组有显著差异(p小于0.05,p小于0.01)。(摘要截断于250字)